More Buyouts In Biotech? (AUXL, HGSI, VRTX)
Everyone is looking for the next or the next to the next biotech and BioHealth merger candidate. Just a day after being worried about major financial losses all over again…. Morningstar has listed this week three of its favorite buyout targets in biotech from its pool of large pharmaceuticals, devices, instruments, and services companies.
Those are Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL), Human Genome Sciences Inc. (NASDAQ: HGSI), and Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX). While we have a brief synopsis here in the image from Morningstar, the full article goes into more detail.
Of the three merger candidates here, Human Genome Sciences (HGSI) seems the biggest risk because its shares could have been acquired for far cheaper when it was weak and chasing it now would perhaps only make sense for its existing drup partner companies.
JON C. OGG
Comments
Leave a Reply
